# Structure-coevolution dual-guided engineering of C-glycosyltransferase enables high-level biosynthesis of vitexin in Yarrowia lipolytica

**Authors:** Chu-Qi Shi, Yi-Jing Chen, Wen-Li Yang, Shuang Zheng, Rong Cai, Jin Hou, De-Qing Wang, Ju-Zheng Sheng

PMC · DOI: 10.1016/j.synbio.2026.02.011 · Synthetic and Systems Biotechnology · 2026-03-09

## TL;DR

Scientists improved an enzyme to efficiently produce a valuable flavonoid in yeast, enabling sustainable biosynthesis.

## Contribution

A structure-coevolution dual-guided strategy enhanced C-glycosyltransferase activity and enabled high vitexin production in Yarrowia lipolytica.

## Key findings

- Engineered TcCGT1 variant M7 showed 43.1-fold higher activity toward apigenin and up to 55.0-fold for other substrates.
- Metabolic engineering in Yarrowia lipolytica achieved 361.0 mg/L vitexin, a 6.3-fold improvement over wild-type.
- Fed-batch fermentation produced 2.14 g/L vitexin, demonstrating industrial scalability.

## Abstract

Flavonoid C-glycosides are bioactive compounds with significant pharmaceutical potential. While biosynthesis offers a sustainable and green alternative to traditional chemical synthesis, its industrial scalability has been hindered by the poor catalytic efficiency and low thermostability of natural C-glycosyltransferases (CGTs). In this study, we report a structure-coevolution dual-guided engineering strategy to modify TcCGT1 from Trollius chinensis, a pivotal enzyme in flavonoid C-glycosylation. The engineered variant M7 exhibited a 43.1-fold improvement in catalytic activity toward apigenin and up to 55.0-fold enhancement for other flavonoid acceptors. It also exhibited an 9.2-fold increase in half-life at 30 °C. Molecular dynamics simulations and structural analyses revealed that the mutations remodeled the substrate-binding cavity and optimized its interactions. To translate this enzymatic advance into a biosynthetic platform, we integrated the optimized variant into a de novo synthetic pathway and conducted metabolic engineering in Yarrowia lipolytica. This integration achieved a vitexin titer of 361.0 mg/L, a 6.3-fold improvement over the wild-type-expressing strain. Furthermore, the engineered microbial cell factory produced 2.14 g/L of vitexin in fed-batch fermentation, demonstrating industrial potential. This study provides new prospects for the structure-coevolution dual-guided synergistic framework of CGT engineering and a sustainable synthetic biology platform for high-value flavonoid C-glycosides.

Image 1

## Linked entities

- **Proteins:** E(spl)m7-HLH (Enhancer of split m7, helix-loop-helix)
- **Chemicals:** vitexin (PubChem CID 5280441), apigenin (PubChem CID 5280443)
- **Species:** Trollius chinensis (taxon 78479), Yarrowia lipolytica (taxon 4952)

## Full-text entities

- **Chemicals:** apigenin (MESH:D047310), flavonoid (MESH:D005419), vitexin (MESH:C032731), CGT (-)
- **Species:** Yarrowia lipolytica (species) [taxon 4952], Trollius (genus) [taxon 39245]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12993211/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12993211/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12993211/full.md

---
Source: https://tomesphere.com/paper/PMC12993211